Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lenses, Intraocular | 31 | 2024 | 346 | 5.260 |
Why?
|
| Phacoemulsification | 23 | 2024 | 221 | 4.310 |
Why?
|
| Lens Implantation, Intraocular | 28 | 2024 | 314 | 4.030 |
Why?
|
| Cornea | 21 | 2024 | 638 | 3.810 |
Why?
|
| Astigmatism | 13 | 2020 | 156 | 3.410 |
Why?
|
| Corneal Topography | 16 | 2019 | 168 | 3.060 |
Why?
|
| Refraction, Ocular | 25 | 2024 | 289 | 2.990 |
Why?
|
| Myopia | 11 | 2024 | 194 | 2.170 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 10 | 2018 | 104 | 1.930 |
Why?
|
| Optics and Photonics | 10 | 2024 | 146 | 1.880 |
Why?
|
| Cataract Extraction | 6 | 2020 | 184 | 1.860 |
Why?
|
| Biometry | 15 | 2024 | 241 | 1.840 |
Why?
|
| Axial Length, Eye | 9 | 2024 | 48 | 1.570 |
Why?
|
| Visual Acuity | 24 | 2024 | 873 | 1.390 |
Why?
|
| Cytomegalovirus Retinitis | 5 | 2013 | 16 | 1.030 |
Why?
|
| Ophthalmology | 4 | 2020 | 198 | 0.980 |
Why?
|
| Corneal Diseases | 3 | 2019 | 89 | 0.960 |
Why?
|
| Cataract | 6 | 2023 | 218 | 0.950 |
Why?
|
| AIDS-Related Opportunistic Infections | 5 | 2013 | 163 | 0.940 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2013 | 317 | 0.920 |
Why?
|
| Keratoconus | 3 | 2023 | 53 | 0.890 |
Why?
|
| Technology Assessment, Biomedical | 2 | 2020 | 59 | 0.880 |
Why?
|
| Academies and Institutes | 3 | 2020 | 95 | 0.860 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2021 | 48 | 0.830 |
Why?
|
| Photorefractive Keratectomy | 6 | 2021 | 77 | 0.810 |
Why?
|
| Corneal Pachymetry | 4 | 2018 | 19 | 0.790 |
Why?
|
| Refractive Errors | 4 | 2018 | 95 | 0.790 |
Why?
|
| Refractive Surgical Procedures | 3 | 2023 | 64 | 0.750 |
Why?
|
| Eye Diseases | 2 | 2024 | 132 | 0.740 |
Why?
|
| Ophthalmic Solutions | 2 | 2019 | 101 | 0.720 |
Why?
|
| Anterior Eye Segment | 2 | 2017 | 32 | 0.700 |
Why?
|
| Multifocal Intraocular Lenses | 2 | 2017 | 13 | 0.700 |
Why?
|
| Serum | 1 | 2019 | 68 | 0.690 |
Why?
|
| Eye Foreign Bodies | 1 | 2018 | 14 | 0.650 |
Why?
|
| Corneal Injuries | 1 | 2018 | 29 | 0.640 |
Why?
|
| Interferometry | 2 | 2017 | 23 | 0.630 |
Why?
|
| Corneal Ulcer | 1 | 2018 | 49 | 0.620 |
Why?
|
| Keratomileusis, Laser In Situ | 5 | 2024 | 129 | 0.610 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 129 | 0.600 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 96 | 0.600 |
Why?
|
| Models, Anatomic | 1 | 2018 | 154 | 0.590 |
Why?
|
| Microsurgery | 2 | 2012 | 244 | 0.590 |
Why?
|
| Corneal Wavefront Aberration | 2 | 2015 | 20 | 0.550 |
Why?
|
| Iris Diseases | 1 | 2015 | 12 | 0.540 |
Why?
|
| Dry Eye Syndromes | 1 | 2019 | 286 | 0.530 |
Why?
|
| Tomography, Optical Coherence | 8 | 2019 | 501 | 0.530 |
Why?
|
| Acanthamoeba Keratitis | 2 | 2021 | 16 | 0.530 |
Why?
|
| Keratotomy, Radial | 2 | 2016 | 26 | 0.520 |
Why?
|
| Descemet Membrane | 2 | 2012 | 10 | 0.470 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2012 | 6 | 0.440 |
Why?
|
| Lasers, Excimer | 4 | 2021 | 86 | 0.420 |
Why?
|
| Humans | 73 | 2024 | 261506 | 0.410 |
Why?
|
| Hyperopia | 3 | 2021 | 84 | 0.390 |
Why?
|
| Epithelium, Corneal | 3 | 2019 | 223 | 0.390 |
Why?
|
| Iris | 4 | 2015 | 67 | 0.380 |
Why?
|
| Reproducibility of Results | 11 | 2019 | 6009 | 0.370 |
Why?
|
| Retrospective Studies | 28 | 2024 | 37905 | 0.370 |
Why?
|
| Prospective Studies | 18 | 2024 | 12873 | 0.370 |
Why?
|
| Corneal Stroma | 3 | 2021 | 80 | 0.360 |
Why?
|
| Suture Techniques | 6 | 2017 | 319 | 0.330 |
Why?
|
| Prosthesis Design | 6 | 2024 | 749 | 0.300 |
Why?
|
| Middle Aged | 30 | 2019 | 86204 | 0.290 |
Why?
|
| Functional Laterality | 1 | 2008 | 316 | 0.280 |
Why?
|
| Antiprotozoal Agents | 2 | 2021 | 40 | 0.280 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 388 | 0.260 |
Why?
|
| Eye | 2 | 2024 | 301 | 0.260 |
Why?
|
| Male | 36 | 2019 | 123000 | 0.250 |
Why?
|
| Uveitis | 2 | 2011 | 33 | 0.250 |
Why?
|
| Ectopia Lentis | 3 | 2015 | 12 | 0.240 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2013 | 297 | 0.240 |
Why?
|
| Organ Size | 2 | 2018 | 690 | 0.240 |
Why?
|
| Sclera | 2 | 2014 | 69 | 0.230 |
Why?
|
| Female | 35 | 2019 | 141928 | 0.220 |
Why?
|
| Aged | 20 | 2019 | 70117 | 0.220 |
Why?
|
| Pseudophakia | 3 | 2018 | 68 | 0.220 |
Why?
|
| Retinopathy of Prematurity | 2 | 2016 | 88 | 0.220 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 29902 | 0.220 |
Why?
|
| Ganciclovir | 1 | 2013 | 174 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 1033 | 0.210 |
Why?
|
| Keratitis | 2 | 2021 | 102 | 0.210 |
Why?
|
| Phosphorylcholine | 1 | 2021 | 54 | 0.200 |
Why?
|
| Artificial Lens Implant Migration | 2 | 2018 | 9 | 0.200 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2011 | 5 | 0.200 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2024 | 171 | 0.200 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 41 | 0.200 |
Why?
|
| Receptors, CCR5 | 1 | 2011 | 52 | 0.200 |
Why?
|
| Adult | 21 | 2019 | 77950 | 0.190 |
Why?
|
| Fourier Analysis | 2 | 2018 | 94 | 0.190 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 132 | 0.190 |
Why?
|
| Wound Healing | 3 | 2012 | 815 | 0.190 |
Why?
|
| Ligaments | 1 | 2020 | 43 | 0.190 |
Why?
|
| Lens, Crystalline | 2 | 2018 | 155 | 0.170 |
Why?
|
| Amblyopia | 1 | 2019 | 112 | 0.170 |
Why?
|
| Preservation, Biological | 1 | 2018 | 15 | 0.170 |
Why?
|
| Light | 2 | 2017 | 245 | 0.160 |
Why?
|
| Postoperative Complications | 6 | 2019 | 5542 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 362 | 0.160 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 51 | 0.160 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2017 | 8 | 0.160 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2017 | 12 | 0.160 |
Why?
|
| Photography | 2 | 2015 | 139 | 0.150 |
Why?
|
| China | 1 | 2019 | 606 | 0.150 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 350 | 0.150 |
Why?
|
| Intraoperative Complications | 2 | 2017 | 301 | 0.150 |
Why?
|
| Dilatation, Pathologic | 1 | 2017 | 88 | 0.150 |
Why?
|
| Eyelids | 1 | 2018 | 163 | 0.150 |
Why?
|
| Anterior Chamber | 1 | 2017 | 51 | 0.140 |
Why?
|
| Term Birth | 1 | 2016 | 30 | 0.140 |
Why?
|
| United States | 7 | 2020 | 15433 | 0.140 |
Why?
|
| Reference Standards | 1 | 2017 | 339 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2013 | 1230 | 0.130 |
Why?
|
| Retinal Detachment | 2 | 2010 | 88 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 5539 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 144 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 187 | 0.130 |
Why?
|
| Collagen | 1 | 2018 | 752 | 0.120 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2014 | 41 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2018 | 785 | 0.120 |
Why?
|
| gamma-Linolenic Acid | 1 | 2013 | 4 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2018 | 769 | 0.120 |
Why?
|
| Treatment Outcome | 11 | 2021 | 32848 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1032 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2016 | 297 | 0.120 |
Why?
|
| Keratoconjunctivitis Sicca | 1 | 2013 | 49 | 0.110 |
Why?
|
| Tears | 2 | 2013 | 181 | 0.110 |
Why?
|
| Corneal Surgery, Laser | 1 | 2013 | 19 | 0.110 |
Why?
|
| Endothelium, Corneal | 1 | 2012 | 33 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2013 | 83 | 0.110 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 14889 | 0.110 |
Why?
|
| Vitrectomy | 2 | 2010 | 100 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2018 | 899 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 220 | 0.110 |
Why?
|
| Intraocular Pressure | 1 | 2013 | 146 | 0.110 |
Why?
|
| Postoperative Period | 3 | 2018 | 665 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 1375 | 0.100 |
Why?
|
| Cell Count | 1 | 2012 | 508 | 0.100 |
Why?
|
| Premature Birth | 1 | 2016 | 407 | 0.100 |
Why?
|
| Meibomian Glands | 1 | 2011 | 33 | 0.100 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 18 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 2403 | 0.100 |
Why?
|
| Cyclophosphamide | 1 | 2018 | 3001 | 0.100 |
Why?
|
| Pupil Disorders | 1 | 2010 | 22 | 0.100 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 76 | 0.090 |
Why?
|
| Aphakia, Postcataract | 3 | 2017 | 19 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 1439 | 0.090 |
Why?
|
| Disease Management | 1 | 2016 | 1052 | 0.090 |
Why?
|
| Sjogren's Syndrome | 1 | 2011 | 102 | 0.090 |
Why?
|
| Photic Stimulation | 1 | 2010 | 259 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2017 | 1270 | 0.090 |
Why?
|
| Laser Coagulation | 1 | 2010 | 136 | 0.090 |
Why?
|
| Viral Load | 2 | 2011 | 493 | 0.080 |
Why?
|
| Physical Examination | 1 | 2010 | 299 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 1648 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 1162 | 0.080 |
Why?
|
| Young Adult | 7 | 2019 | 21445 | 0.080 |
Why?
|
| Benzamidines | 1 | 2008 | 12 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2021 | 16273 | 0.080 |
Why?
|
| Risk Factors | 5 | 2017 | 17523 | 0.080 |
Why?
|
| Child | 9 | 2021 | 29154 | 0.080 |
Why?
|
| Contact Lenses | 1 | 2008 | 45 | 0.080 |
Why?
|
| Vision, Binocular | 1 | 2008 | 71 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2017 | 1375 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 1863 | 0.070 |
Why?
|
| Neurons | 1 | 2016 | 2287 | 0.070 |
Why?
|
| Adolescent | 7 | 2016 | 31252 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2992 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 1171 | 0.060 |
Why?
|
| Tonometry, Ocular | 1 | 2024 | 32 | 0.060 |
Why?
|
| Corneal Neovascularization | 1 | 2003 | 14 | 0.060 |
Why?
|
| Time Factors | 4 | 2019 | 12926 | 0.060 |
Why?
|
| Prednisolone | 1 | 2003 | 123 | 0.060 |
Why?
|
| Drug Implants | 1 | 2013 | 46 | 0.060 |
Why?
|
| Lasers | 1 | 2024 | 198 | 0.060 |
Why?
|
| Lissamine Green Dyes | 2 | 2013 | 7 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 338 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2013 | 141 | 0.050 |
Why?
|
| Visual Fields | 1 | 2013 | 142 | 0.050 |
Why?
|
| Loteprednol Etabonate | 1 | 2021 | 5 | 0.050 |
Why?
|
| United States Public Health Service | 1 | 2011 | 4 | 0.050 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 23 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2013 | 355 | 0.050 |
Why?
|
| Drug Substitution | 1 | 2021 | 87 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 3260 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 1541 | 0.040 |
Why?
|
| Disease Progression | 2 | 2011 | 6682 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 663 | 0.040 |
Why?
|
| Hospitals, County | 1 | 2017 | 28 | 0.040 |
Why?
|
| Vision Tests | 1 | 2017 | 66 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2013 | 6100 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 344 | 0.040 |
Why?
|
| Contrast Sensitivity | 1 | 2017 | 62 | 0.040 |
Why?
|
| Spiral Ganglion | 1 | 2016 | 11 | 0.040 |
Why?
|
| Aberrometry | 1 | 2017 | 9 | 0.040 |
Why?
|
| Microscopy, Acoustic | 1 | 2017 | 26 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2003 | 927 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2011 | 636 | 0.040 |
Why?
|
| HIV-1 | 1 | 2011 | 653 | 0.030 |
Why?
|
| Tomography | 1 | 2015 | 55 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 1183 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1945 | 0.030 |
Why?
|
| Neuroglia | 1 | 2016 | 223 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2016 | 436 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 41 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2013 | 55 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 4971 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 173 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 4892 | 0.030 |
Why?
|
| Retinoscopy | 1 | 2012 | 10 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 4109 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1890 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 1069 | 0.030 |
Why?
|
| Nylons | 1 | 2012 | 19 | 0.030 |
Why?
|
| Rupture | 1 | 2012 | 61 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 4988 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 429 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 60 | 0.030 |
Why?
|
| Sutures | 1 | 2012 | 86 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 5673 | 0.030 |
Why?
|
| Conjunctiva | 1 | 2013 | 250 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2011 | 234 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 3869 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 667 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 9244 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 4549 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 9180 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 2588 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 117 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 13310 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 4314 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 4053 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 6295 | 0.020 |
Why?
|
| Corneal Edema | 1 | 2003 | 12 | 0.020 |
Why?
|
| Ofloxacin | 1 | 2003 | 41 | 0.010 |
Why?
|
| Aging | 1 | 2012 | 1582 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 3890 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2003 | 629 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 446 | 0.010 |
Why?
|
| Animals | 1 | 2024 | 59536 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 5687 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 2315 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8223 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 15179 | 0.010 |
Why?
|